DATABASE
Home
Database
Who We Are
What We Offer
Register
Sign In
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Name
Category
ANTHERA PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material
News
ANTHERA PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
News
ANTHERA PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors or
News
ANTHERA PHARMACEUTICALS INC Financials
News
Anthera Pharmaceuticals Inc.
Fund
Anthera Pharmaceuticals Management Discusses Q1 2013 Results - Earnings Call Transcript
News
Anthera Pharmaceuticals Reports 2012 Fourth Quarter And Fiscal Year Financial Results
News
Anthera Pharmaceuticals Reports 2013 First Quarter Financial Results
News
Anthera Pharmaceuticals to Present at Annual Jefferies Healthcare Conference
News
Anthera Refinances Existing Debt with New $20 Million Credit Facility and Secures $18.5 Million Committed Equity Financing Facility
News
Anthilia Capital Partners cl A Quota di partecipazione (nominativo) /2010
Fund
Anthilia Capital Partners Sgr Spa
Company
Anthilia Orange Quota di Partecipazione 2003-31 12 2100 Accumulation
Fund
Anthilia Yellow Quota di Partecipazione accumulazione
Fund
Anthium Finance
Bank
Anthony Abbenante
Contact
Anthony Alvaro
Contact
Anthony Ambrose
Contact
Anthony Antonopoulos
Contact
Anthony Ball
Contact
Anthony Billis
Contact
Anthony Billis
Contact
Anthony Brittain
Contact
Anthony Businskas
Contact
Anthony Caputo
Contact
Page 683 of 1100